
FDA Approves Epidiolex, First Cannabis-Based Medication for Epilepsy in U.S
The FDA has approved Epidiolex, the first cannabis-based medication in the U.S., for treating severe epilepsy in children over two years old
- •FDA approves Epidiolex for severe childhood epilepsy
- •Epidiolex targets Dravet and Lennox-Gastaut syndromes
- •Epidiolex contains 98% CBD and less than 0.1% THC
- •GW Pharmaceutical developed Epidiolex in the UK
by fda-epidiolex-etats-unis



















